Related references
Note: Only part of the references are listed.A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib
Pat Ricalde et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2019)
Pediatric reference intervals for 1,25-dihydroxyvitamin D using the DiaSorin LIAISON XL assay in the healthy CALIPER cohort
Victoria Higgins et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation
Natacha Kadlub et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes
Corinne Collet et al.
JBMR PLUS (2018)
Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism
Natacha Kadlub et al.
HUMAN PATHOLOGY (2016)
The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism
Natacha Kadlub et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages
Virginie Prod'Homme et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
SH3BP2 Cherubism Mutation Potentiates TNF-α-Induced Osteoclastogenesis via NFATc1 and TNF-α-Mediated Inflammatory Bone Loss
Tomoyuki Mukai et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Interpretation of Plasma PTH Concentrations According to 25OHD Status, Gender, Age, Weight Status, and Calcium Intake: Importance of the Reference Values
Mathilde Touvier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism
Teruhito Yoshitaka et al.
CELL REPORTS (2014)
Anti-tumor necrosis factor treatment in cherubism - Clinical, radiological and histological findings in two children
M. Hero et al.
BONE (2013)
Pediatric reference intervals for four serum bone markers using two automated immunoassays
Sara P. Wyness et al.
CLINICA CHIMICA ACTA (2013)
Nocturnal mouthpiece ventilation and medical hypnosis to treat severe obstructive sleep apnea in a child with cherubism
Sonia Khirani et al.
PEDIATRIC PULMONOLOGY (2013)
Cherubism: best clinical practice
Maria E. Papadaki et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
The role of SH3BP2 in the pathophysiology of cherubism
Ernst J. Reichenberger et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
Noam Levaot et al.
CELL (2011)
3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions
Noam Levaot et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter - Case Report
L. Preda et al.
MOLECULAR SYNDROMOLOGY (2010)
Osteoporosis in Inflammatory Bowel Disease
Tauseef Ali et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery
V. V. Roginsky et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions
E. Michael Lewiecki et al.
BONE (2008)
Two-stage surgical treatment of severe Cherubism
Cassio Eduardo Raposo-Amaral et al.
ANNALS OF PLASTIC SURGERY (2007)
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 cherubism mice
Yasuyoshi Ueki et al.
CELL (2007)
An extreme case of cherubism
EC Silva et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2002)
Cherubism and its charlatans
DA Lannon et al.
BRITISH JOURNAL OF PLASTIC SURGERY (2001)
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism
Y Ueki et al.
NATURE GENETICS (2001)
Share Paper
